This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The United States of America. Active years: 1998.
Company Filing History:
Years Active: 1998
Title: Glenn Merlino: Innovator in Transgenic Technology
Introduction
Glenn Merlino is a notable inventor based in Vienna, VA (US). He has made significant contributions to the field of biotechnology, particularly in the development of transgenic animals. His work focuses on enhancing the understanding of multidrug resistance in cells.
Latest Patents
Merlino holds a patent for "Transgenic animals expressing a multidrug resistance cDNA." This invention provides vectors carrying a cDNA that contains the entire coding region of the human multidrug resistance gene (MDR1). The method introduced by Merlino allows for the introduction of MDR1 cDNA into cells, thereby inducing a multidrug resistant phenotype. He has 1 patent to his name.
Career Highlights
Throughout his career, Glenn Merlino has been associated with the United States of America, where he has worked on various innovative projects. His research has contributed to advancements in understanding drug resistance, which is crucial for developing effective treatments.
Collaborations
Merlino has collaborated with esteemed colleagues such as Hanan Galski and Michael M Gottesman. These partnerships have furthered research in the field and have led to significant findings in transgenic technology.
Conclusion
Glenn Merlino's work in transgenic technology and his patent on multidrug resistance highlight his contributions to biotechnology. His innovative approach continues to influence the field and pave the way for future advancements.